Skip to main content

Vicarious Surgical Inc.

corporate_fare Company Profile

Vicarious Surgical Inc.

RBOT·OTC·Life Sciences·CIK 0001812173

Vicarious Surgical is developing a new category of intelligent and affordable single-port surgical robots for minimally invasive surgery. The company combines advanced miniaturized robotics, computer science, sensing, and 3D visualization. Its next-generation robotics technology is being designed with proprietary human-like motion to improve surgical precision, ergonomics, and procedural efficiency. The goal is to improve patient outcomes and the cost and efficacy of surgical procedures over time. The company's single-port surgical robot, called the Vicarious Surgical System, is designed to address limitations of current robot-assisted minimally invasive surgery. If authorized by the FDA, the Vicarious Surgical System will allow surgeons to perform procedures with greater dexterity and access across the abdomen, with better visibility and sensor-based feedback, through a small single incision. The system features proprietary "de-coupled" actuators, which are intended to improve robotic mobility, reduce size, enhance functionality, and lower materials costs. If authorized by the FDA, the Vicarious Surgical System is designed to enable surgeons to perform procedures inside the abdomen with human-equivalent motion, offering nine degrees of freedom per robotic arm, to provide a more natural experience akin to a surgeon's own upper body movements.

Vicarious Surgical Inc. (OTC:RBOT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for RBOT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-04-30, rated 9/10. Across its 11 most recent items scored 7 or higher, the top rating is 10/10, with 8 rated 8 or above. Recent SEC coverage for RBOT spans 8-K, SCHEDULE 13D/A, DEF 14A, 10-K.

Recent high-impact activity:

  • Vicarious Surgical's Cash Runway Limited to Q2 Amid Q1 Loss, No Revenue
  • Stockholders Approve Reverse Stock Split to Address Listing Compliance
  • Major Investor Sells Over 50% Stake, Drops Below 5% Ownership Amidst Going Concern Doubts
  • Vicarious Surgical Schedules Special Meeting to Vote on Reverse Stock Split for Nasdaq Relisting Bid
  • Vicarious Surgical Reports Drastic Cash Burn Reduction, Confirms NYSE Delisting and OTC Move

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 71,545 shares in RBOT as of the September 15, 2026 settlement, a 27.5% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 42.7% of RBOT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)71,545 shares as of September 15, 2026
Change vs prior period▼ 27.5%
Days to cover1.00 at avg daily volume of 92,023
Daily short volume (FINRA facilities)42.7% of 41,466 shares on October 2, 2026
5-day average short volume61.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$0.0548 -0.03% today
52-week range · as of 2026-04-08 $0.0548 – $13.75
Market cap
$390.8K
Volume
41.5K (0.8× avg)
3-mo avg 51.9K
Live data · 2026-10-03 16:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RBOT - Latest Insights

RBOT
Apr 30, 2026, 9:01 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.550
Real-time Price: $0.0548 info
Change: -$0.4952 (-90%) info
Market Cap: $390.798K info
RBOT
Apr 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.0548 info
Change: -$0.7252 (-93%) info
Market Cap: $390.798K info
RBOT
Apr 06, 2026, 7:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.0548 info
Change: -$0.7252 (-93%) info
Market Cap: $390.798K info
RBOT
Mar 23, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.960
Real-time Price: $0.0548 info
Change: -$0.9052 (-94%) info
Market Cap: $390.798K info
RBOT
Mar 09, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.371
Real-time Price: $0.0548 info
Change: -$0.3162 (-85%) info
Market Cap: $390.798K info
RBOT
Mar 09, 2026, 4:16 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.371
Real-time Price: $0.0548 info
Change: -$0.3162 (-85%) info
Market Cap: $390.798K info
RBOT
Mar 06, 2026, 4:33 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.270
Real-time Price: $0.0548 info
Change: -$0.2152 (-80%) info
Market Cap: $390.798K info
RBOT
Mar 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.270
Real-time Price: $0.0548 info
Change: -$0.2152 (-80%) info
Market Cap: $390.798K info
RBOT
Mar 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
10
Price at Filing: $1.98
Real-time Price: $0.0548 info
Change: -$1.93 (-97%) info
Market Cap: $390.798K info
RBOT
Feb 02, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $0.0548 info
Change: -$2.04 (-97%) info
Market Cap: $390.798K info
RBOT
Jan 09, 2026, 4:53 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.61
Real-time Price: $0.0548 info
Change: -$2.56 (-98%) info
Market Cap: $390.798K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets